Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients.

Authors :: Boyarsky BJ
Chiang TP
Teles AT
Greenberg RS
Krach MR
Ou MT
Massie AB
Tobian AAR
Garonzik-Wang JM
Segev DL
Werbel AWA
Source :: Transplantation [Transplantation] 2021 Oct 01; Vol. 105 (10), pp. e137-e138.
Publication Year :: 2021
Abstract: Competing Interests: D.L.S. has the following financial disclosures: consulting and speaking honoraria from Sanofi, Novartis, CSL Behring, Jazz Pharmaceuticals, Veloxis, Mallinckrodt, and Thermo Fisher Scientific. The remaining authors of this manuscript have no financial disclosures or conflicts of interest to disclose as described by Transplantation.

Subjects :: Humans
Kinetics
mRNA Vaccines
Antibodies, Viral blood
COVID-19 prevention & control
COVID-19 Vaccines immunology
Organ Transplantation
SARS-CoV-2 immunology
Vaccination
Vaccines, Synthetic immunology

Full Text Access

Tools